These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 20155945)
21. A novel anticancer agent, decursin, induces G1 arrest and apoptosis in human prostate carcinoma cells. Yim D; Singh RP; Agarwal C; Lee S; Chi H; Agarwal R Cancer Res; 2005 Feb; 65(3):1035-44. PubMed ID: 15705905 [TBL] [Abstract][Full Text] [Related]
22. Identification of proteins binding to decursinol by chemical proteomics. Kang HJ; Yoon TS; Jeong DG; Kim Y; Chung JW; Ha JS; Park SS; Ryu SE; Kim S; Bae KH; Chung SJ J Microbiol Biotechnol; 2008 Aug; 18(8):1427-30. PubMed ID: 18756104 [TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetic characterization of decursinol derived from Angelica gigas Nakai in rats. Song JS; Chae JW; Lee KR; Lee BH; Choi EJ; Ahn SH; Kwon KI; Bae MA Xenobiotica; 2011 Oct; 41(10):895-902. PubMed ID: 21657833 [TBL] [Abstract][Full Text] [Related]
24. Prostate Cancer Xenograft Inhibitory Activity and Pharmacokinetics of Decursinol, a Metabolite of Angelica gigas Pyranocoumarins, in Mouse Models. Wu W; Tang SN; Zhang Y; Puppala M; Cooper TK; Xing C; Jiang C; Lü J Am J Chin Med; 2017; 45(8):1773-1792. PubMed ID: 29121805 [TBL] [Abstract][Full Text] [Related]
25. In vitro inhibitory potential of decursin and decursinol angelate on the catalytic activity of cytochrome P-450 1A1/2, 2D15, and 3A12 isoforms in canine hepatic microsomes. Abd El-Aty AM; Shah SS; Kim BM; Choi JH; Cho HJ; Hee-Yi ; Chang BJ; Shin HC; Lee KB; Shimoda M; Shim JH Arch Pharm Res; 2008 Nov; 31(11):1425-35. PubMed ID: 19023539 [TBL] [Abstract][Full Text] [Related]
26. Rapid and Efficient Separation of Decursin and Decursinol Angelate from Kiyonga AN; An JH; Lee KY; Lim C; Suh YG; Chin YW; Jung K Molecules; 2019 Jun; 24(13):. PubMed ID: 31261662 [TBL] [Abstract][Full Text] [Related]
27. Absorption, distribution, metabolism, and excretion of decursin and decursinol angelate from Angelica gigas Nakai. Kim KM; Kim MJ; Kang JS J Microbiol Biotechnol; 2009 Dec; 19(12):1569-72. PubMed ID: 20075620 [TBL] [Abstract][Full Text] [Related]
28. Decursin and decursinol from Angelica gigas inhibit the lung metastasis of murine colon carcinoma. Son SH; Park KK; Park SK; Kim YC; Kim YS; Lee SK; Chung WY Phytother Res; 2011 Jul; 25(7):959-64. PubMed ID: 21170925 [TBL] [Abstract][Full Text] [Related]
29. Overexpression of cinnamate 4-hydroxylase gene enhances biosynthesis of decursinol angelate in Angelica gigas hairy roots. Park NI; Park JH; Park SU Mol Biotechnol; 2012 Feb; 50(2):114-20. PubMed ID: 21626264 [TBL] [Abstract][Full Text] [Related]
30. Anti-tumor activities of decursinol angelate and decursin from Angelica gigas. Lee S; Lee YS; Jung SH; Shin KH; Kim BK; Kang SS Arch Pharm Res; 2003 Sep; 26(9):727-30. PubMed ID: 14560921 [TBL] [Abstract][Full Text] [Related]
31. Involvement of PKC and ROS in the cytotoxic mechanism of anti-leukemic decursin and its derivatives and their structure-activity relationship in human K562 erythroleukemia and U937 myeloleukemia cells. Kim HH; Sik Bang S; Seok Choi J; Han H; Kim IH Cancer Lett; 2005 Jun; 223(2):191-201. PubMed ID: 15896453 [TBL] [Abstract][Full Text] [Related]
32. Pyranocoumarin Tissue Distribution, Plasma Metabolome and Prostate Transcriptome Impacts of Sub-Chronic Exposure to Korean Angelica Supplement in Mice. Zhang J; Li L; Tang S; Zhang Y; Markiewski M; Xing C; Jiang C; Lü J Am J Chin Med; 2016; 44(2):321-53. PubMed ID: 27080944 [TBL] [Abstract][Full Text] [Related]
33. Neuroprotective Potential of Pyranocoumarins from Tran NKS; Trinh TA; Pyo J; Kim CG; Park JG; Kang KS Antioxidants (Basel); 2023 Aug; 12(8):. PubMed ID: 37627646 [TBL] [Abstract][Full Text] [Related]
34. Physicochemical characterization and toxicity of decursin and their derivatives from Angelica gigas. Mahat B; Chae JW; Baek IH; Song GY; Song JS; Cho SK; Kwon KI Biol Pharm Bull; 2012; 35(7):1084-90. PubMed ID: 22791156 [TBL] [Abstract][Full Text] [Related]
35. Anti-Inflammatory Effect of Angelica gigas via Heme Oxygenase (HO)-1 Expression. Cho JH; Kwon JE; Cho Y; Kim I; Kang SC Nutrients; 2015 Jun; 7(6):4862-74. PubMed ID: 26083119 [TBL] [Abstract][Full Text] [Related]
36. Chemistry, Pharmacology and Therapeutic Potential of Decursin: A Promising Natural Lead for New Drug Discovery and Development. Muralikrishnan A; Sekar M; Kumarasamy V; Gan SH; Ravi S; Subramaniyan V; Wong LS; Wu YS; Khattulanuar FS; Mat Rani NNI Drug Des Devel Ther; 2024; 18():3741-3763. PubMed ID: 39286287 [TBL] [Abstract][Full Text] [Related]
37. Anti-cancer and other bioactivities of Korean Angelica gigas Nakai (AGN) and its major pyranocoumarin compounds. Zhang J; Li L; Jiang C; Xing C; Kim SH; Lü J Anticancer Agents Med Chem; 2012 Dec; 12(10):1239-54. PubMed ID: 22583405 [TBL] [Abstract][Full Text] [Related]
38. Protection against beta-amyloid peptide-induced memory impairment with long-term administration of extract of Angelica gigas or decursinol in mice. Yan JJ; Kim DH; Moon YS; Jung JS; Ahn EM; Baek NI; Song DK Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):25-30. PubMed ID: 14687853 [TBL] [Abstract][Full Text] [Related]
39. Potent inhibition of monoamine oxidase A by decursin from Angelica gigas Nakai and by wogonin from Scutellaria baicalensis Georgi. Lee HW; Ryu HW; Kang MG; Park D; Lee H; Shin HM; Oh SR; Kim H Int J Biol Macromol; 2017 Apr; 97():598-605. PubMed ID: 28109809 [TBL] [Abstract][Full Text] [Related]
40. Decursin inhibits VEGF-mediated inner blood-retinal barrier breakdown by suppression of VEGFR-2 activation. Kim JH; Kim JH; Lee YM; Ahn EM; Kim KW; Yu YS J Cereb Blood Flow Metab; 2009 Sep; 29(9):1559-67. PubMed ID: 19536074 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]